The global market for prefilled syringes is expanding, driven by the rising prevalence of chronic illnesses, greater use of biologics and biosimilars, and a growing trend toward self-injection.

The global prefilled syringes market share is projected to grow from US$ 6.69 Billion in 2022 to US$ 15.0 Billion by 2030, ...

The FDA has accepted for review the sBLA for fremanezumab-vfrm for the prevention of episodic migraine in pediatric patients aged 6 to-17 years weighing at least 45 kg.

As of Wednesday, April 09, scPharmaceuticals Inc.’s SCPH share price has dipped by 9.30%, which has investors questioning if ...

South Korea Prefilled Syringes Market The South Korea prefilled syringes market is expected to grow at a CAGR of 4.32% from 2024 to 2032, d ...

Enable Injections’ enFuse Syringe Transfer System has secured CE mark approval under the European Union Medical Device ...

Regeneron’s Eylea franchise remains resilient despite biosimilar competition. Read what makes REGN stock a Strong Buy despite ...

SMi are pleased to present the 12 th Annual Pre-Filled Syringes and Injectable Drug Devices conference in London on 15 th and 16 th January 2020. As Europe’s leading Pre-Filled Syringes ...

SMi reports: West Pharmaceutical Services to Host a Free Exclusive Webinar on Prefilled Syringe Elastomer Components High-Quality Solutions for Sensitive Molecules, taking place on 16 th July 2020.

The new single-dose prefilled syringes will be available in 40 USP units/0.5mL and 80 USP units/mL dosage strengths. The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel ...